News from prime therapeutics llc A wide array of domestic and global news stories; news topics include politics/government, business, technology, religion, sports/entertainment, science/nature, and health/lifestyle. Articles that appear in this section may be written in English or other languages.

Latest

Apr 21, 2016, 10:00 ET Two Prime Therapeutics pharmacists achieve awards from Academy of Managed Care Pharmacy

 Two pharmacists from Prime Therapeutics LLC (Prime), a pharmacy benefit manager serving nearly 26 million...


Apr 06, 2016, 11:08 ET Prime Therapeutics Statement on U.S. Food and Drug Administration's Approval of Biosimilar Inflectra

The U.S. Food and Drug Administration's (FDA) approval yesterday of the second U.S. biosimilar, Inflectra™ (infliximab-dyyb), is a positive...


Mar 08, 2016, 14:00 ET Prime Therapeutics to provide pharmacy benefits management to Blue Cross & Blue Shield of Rhode Island

 Prime Therapeutics LLC (Prime) announced today that it will begin managing pharmacy benefits for Blue Cross & Blue Shield of...


Dec 22, 2015, 16:42 ET Prime Therapeutics prefers both cholesterol lowering drugs Praluent® and Repatha® on its national drug list

 Prime Therapeutics LLC (Prime) announced today it will prefer on its national drug list, both Praluent® and Repatha®,...


Dec 22, 2015, 16:42 ET Prime Therapeutics prefers both cholesterol lowering drugs Praluent® and Repatha® on its national drug list

 Prime Therapeutics LLC (Prime) announced today it will prefer on its national drug list, both Praluent® and Repatha®,...


Apr 14, 2015, 08:00 ET Prime Therapeutics names Jim DuCharme president and CEO

 Prime Therapeutics LLC (Prime), a pharmacy benefit manager serving more than 26 million members, announced today...


Apr 06, 2015, 11:37 ET New Cystic Fibrosis Treatments May Significantly Increase Pharmacy Benefit Costs

 Ground-breaking new cystic fibrosis treatments, that target the gene mutations causing the disease, will significantly increase health care...


Apr 06, 2015, 11:25 ET Study: Drug Costs for Rare Hereditary Angioedema Disorder Tripled in Two Years

Hereditary angioedema (HAE) – a rare genetic disorder that results in potentially life-threatening edema or swelling of limbs,...


Apr 06, 2015, 11:19 ET Prime Therapeutics Study Finds Many People May Take Opioids Inappropriately

Even though medical guidelines recommend against prolonged opioid use for conditions such as low back pain, headaches and fibromyalgia, many people...


Mar 23, 2015, 08:30 ET Prime Therapeutics Selects EQuIPP as Platform for Collaboration with Community Pharmacies for Continuous Improvement of Quality

Pharmacy Quality Solutions, Inc. (PQS) announces that it will work with Prime Therapeutics LLC (Prime) to support collaboration of...


Mar 18, 2015, 14:00 ET First full-year look at public exchange member drug usage released by Prime Therapeutics

During the first year public health exchanges existed, Prime Therapeutics' (Prime) members who enrolled in plans on...


Mar 06, 2015, 11:35 ET Prime Therapeutics welcomes FDA's approval of first biosimilar in U.S., but says more clarity is needed

 Prime Therapeutics LLC (Prime), a non-profit pharmacy benefit manager serving more than 26 million members, today released the following...


Mar 03, 2015, 12:07 ET Prime Therapeutics receives PBMI's 2015 Rx Innovation Award

Prime Therapeutics LLC (Prime) received the Pharmacy Benefit Management Institute's (PBMI) 2015 Rx Innovation Award today in...


Feb 24, 2015, 09:00 ET Great Expectations for U.S. Biosimilars, But Prime Therapeutics Warns Regulatory Decisions May Reduce Savings

 The imminent approval of the first biosimilars in the U.S. brings widespread optimism that they will stem the tide of soaring specialty drug...


Feb 16, 2015, 14:00 ET Prime Therapeutics study links controlled substances score to health outcomes, cost of care

In the past decade, drug overdose deaths have more than doubled and over 50 percent were related to prescription drugs.1 To help curb this...


Apr 29, 2014, 09:00 ET Prime Therapeutics ranks highest in customer satisfaction for two consecutive years

 For a second year, Prime Therapeutics LLC (Prime) received top rating for overall customer satisfaction and most likely to recommend for...


Apr 03, 2014, 09:00 ET Prime Therapeutics Study Finds Members Using its Specialty Pharmacy More Likely to Stay on Medicines Than Those Filling Prescriptions at Retail Pharmacies

Receiving specialty drugs through Prime Therapeutics Specialty Pharmacy LLC rather than a retail pharmacy store is associated with...


Apr 03, 2014, 09:00 ET Prime Therapeutics celebrates 10-year anniversary in Irving, Texas

 Today, Prime Therapeutics LLC (Prime) celebrated its expansion from 100 employees to 800 employees in the 10 years it has been...


Apr 02, 2014, 09:00 ET Prime Therapeutics Study Finds Patients More Likely to Start Specialty Medications When Out-of-Pocket Costs Are Under $250

 Pharmacy plan members with specialty drug out-of-pocket costs (OOP) less than $250 are more likely to start taking their medication than those...


Apr 01, 2014, 09:00 ET Prime Therapeutics study finds high risk opioid users have medical costs three times higher than other opioid users

 People who are at high-risk for opioid abuse use had significantly higher total medical costs ($19,513 vs. $5,493) than those...


Mar 31, 2014, 09:00 ET Prime Therapeutics study finds intervention can reduce use and cost of controlled substances among high risk users

In 2010, nearly 15,000 people died from overdoses involving prescription painkillers—more than those who died from heroin...


Feb 04, 2014, 19:02 ET Prime Therapeutics Specialty Pharmacy helped nearly 20,000 members save $21.2 million on specialty medicines in 2013

 Prime Therapeutics LLC (Prime), a leading pharmacy benefit manager, helped nearly 20,000 members save more than $21.2 million...


Dec 11, 2013, 09:00 ET Prime Therapeutics wins five 2013 MarCom Awards

For the outstanding quality and creativity of its video production and business-to-business communications, Prime Therapeutics LLC (Prime), a...


Nov 26, 2013, 08:30 ET Cardinal Health, Prime Therapeutics Renew Primary Distribution Agreement

 Cardinal Health today announced that it has renewed a three-year agreement with Prime Therapeutics (Prime) to continue serving as primary...


Oct 14, 2013, 09:00 ET Expanded use of breast cancer drug Herceptin (trastuzumab) can be effectively tracked by combining pharmacy and medical claims data

Expanded use of the common breast cancer drug Herceptin® (trastuzumab) can be tracked using...